After-Hours Stock Movers 04/28: Zymeworks Gains on Takeover Talk; Amazon Sinks on Miss, Apple Lower on Supply Chain Warning (more...)

Go back to After-Hours Stock Movers 04/28: Zymeworks Gains on Takeover Talk; Amazon Sinks on Miss, Apple Lower on Supply Chain Warning (more...)

Amazon (AMZN) Removed from Wedbush Best Ideas List

May 2, 2022 7:02 AM EDT

Amazon (NASDAQ: AMZN) Removed from Wedbush Best Ideas List

... More

Amazon.com (AMZN) PT Lowered to $3,700 at Jefferies

April 29, 2022 8:40 AM EDT

Jefferies analyst Brent Thill lowered the price target on Amazon.com (NASDAQ: AMZN) to $3,700.00 (from $4,000.00) while maintaining a Buy rating.

The analyst commented, "Elevated costs constrained Op Income and overshadowed another quarter of solid momentum at AWS. We believe the market needs... More

Atlassian Corporation (TEAM) PT Lowered to $285 at Cowen

April 29, 2022 7:22 AM EDT

Cowen analyst Derrick Wood lowered the price target on Atlassian Corporation (NASDAQ: TEAM) to $285.00 (from $330.00) while maintaining a Market Perform rating.

The analyst commented, "TEAM reported rev growth 6% above Street & ST billings growth 7% above, roughly in line w/ recent trends. On-prem (DC,... More

Amazon.com (AMZN) PT Lowered to $2,900 at Rosenblatt

April 29, 2022 7:12 AM EDT

Rosenblatt analyst Barton Crockett lowered the price target on Amazon.com (NASDAQ: AMZN) to $2,900.00 (from $3,000.00) while maintaining a Neutral rating.

The analyst commented, "Amazon.com's impressively large operating losses in its non-AWS segments in 1Q22 are largely transitional. Amazon makes a persuasive argument for $4... More

Intel (INTC) PT Lowered to $55 at Needham & Company

April 29, 2022 7:08 AM EDT

Needham & Company analyst Quinn Bolton lowered the price target on Intel (NASDAQ: INTC) to $55.00 (from $60.00) while maintaining a Buy rating.

The analyst commented, "Intel reported 1Q22 results that were modestly better than expectations, with a stronger GM the main standout. However, the... More

Morgan Stanley Downgrades Accolade Inc. (ACCD) to Equalweight

April 29, 2022 5:48 AM EDT

Morgan Stanley analyst Ricky Goldwasser downgraded Accolade Inc. (NASDAQ: ACCD) from Overweight to Equalweight with a price target of $9.00 (from $30.00).

The analyst comments "We continue to like the long-term growth opportunity for Accolade and recognize sentiment is already very depressed. However, the loss... More